KMI-008, a novel β-Secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-State mimic: design and synthesis of substrate-based octapeptides
- 15 December 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (24) , 4273-4276
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Design and Synthesis of Statine-Based Cell-Permeable Peptidomimetic Inhibitors of Human β-SecretaseJournal of Medicinal Chemistry, 2003
- Design of Substrate-Based Inhibitors of Human β-SecretaseJournal of Medicinal Chemistry, 2001
- Structure-Based Design: Potent Inhibitors of Human Brain Memapsin 2 (β-Secretase)Journal of Medicinal Chemistry, 2001
- Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with InhibitorScience, 2000
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Cellular mechanisms of β-amyloid production and secretionProceedings of the National Academy of Sciences, 1999
- Translating cell biology into therapeutic advances in Alzheimer's diseaseNature, 1999
- Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interactionJournal of Medicinal Chemistry, 1990